News
OXFORD — The New York Giants have given Ole Miss football quarterback Jaxson Dart a chance to break more of Eli Manning's records. The Giants selected Dart with the No. 25 pick in the first ...
Three Gainesville Leopards will pursue their academic and athletic careers at the next level. Chloe Tatum, Matteo Guerreiro and Max Neelley were joined by coaches and family members this week for ...
On Friday, former Rebels and Giants QB Eli Manning officially welcomed Dart to the club. One day after hearing his name called in the first round, Dart made the trip up to the Giants facility ...
Pharmaceutical giant Eli Lilly and Co. sued Willow Health Services and three other companies in federal court in New Jersey and California, accusing them of selling unapproved compounded ...
Less than 24 hours after locking up their All-Pro safety to a lucrative extension, the Detroit Lions are exercising their 2026 fifth-year options on Pro Bowl defensive end Aidan Hutchinson and ...
Will Jaxson Dart be the Giants’ next Eli Manning, after six mostly brutal seasons of Daniel Jones? Maybe. And if the second time is the charm for the Giants in their post-Manning years ...
The Detroit Lions have exercised the fifth-year option of Aidan Hutchinson and Jameson Williams, ensuring that they will be under contract through the 2026 season. Hutchinson, as the No. 2 overall ...
April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs.
Eli Lilly (NYSE: LLY) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a weight loss medicine that's already generating more than $1 billion in ...
Eli Lilly has unleashed another wave of litigation against four telehealth brands in its widening legal war with sellers of alternative versions of its popular diabetes and weight-loss drugs. The ...
The weight loss drug market could grow to $500 billion over the next decade. Eli Lilly's next-generation products look promising, while competitors have stumbled in clinical trials. Investors are ...
On Wednesday, pharmaceutical giant Eli Lilly sued four prominent telehealth companies that offer more affordable, off-brand versions of its patented best-selling GLP-1 medications Mounjaro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results